Free News Archives
Latest Issue of OR Manager
February 2025

Diabetes linked to adverse outcomes after surgery

Editor's Note Patients with diabetes are more likely to have adverse outcomes after surgery, and greater risks are associated with increasing HbA1c levels, this study finds. Of 7,565 patients analyzed, 30% had diabetes and 37% had prediabetes. After adjustments, diabetes was linked to increased: 6-month mortality (9% in patients with…

Read More

By: Judy Mathias
June 25, 2018
Share

Report predicts growth for spinal fusion market

Editor's Note An Acquire Market Research report predicts the global spinal fusion market will grow at a 4.54% compound annual growth rate through 2023, according to the June 21 Becker’s Spine Review. Reasons for the predicted growth are the: growing incidence of spinal deformity cases rising healthcare awareness increase in…

Read More

By: Judy Mathias
June 25, 2018
Share

Joint Commission issues Quick Safety on identifying human trafficking victims

Editor's Note The Joint Commission on June 20 announced “Quick Safety 42: Identifying human trafficking victims.” The Quick Safety focuses on: recognizing signs of human trafficking knowing when to involve law enforcement becoming familiar with community resources that can help the victims.

Read More

By: Judy Mathias
June 25, 2018
Share

QI program results in reduced readmissions, LOS for malnourished surgical patients

Editor's Note Malnourished hospitalized surgical and medical patients who participated in a nutrition quality improvement (QI) program had improved readmission rates and length of stay (LOS), but surgical patients had a significantly greater reduction in readmissions than medical patients, in this study. Of 1,269 patients analyzed, 288 were surgical patients…

Read More

By: Judy Mathias
June 22, 2018
Share

Robot-assisted vs open cystectomy

Editor's Note Robot-assisted and open cystectomies are equally effective in treating bladder cancer, this 7-year study finds. Conducted at 17 institutions, 350 patients with bladder cancer were randomized to the open (175 patients) or the robot-assisted (175 patients) surgical approach. The researchers found lower blood loss and transfusion rates and…

Read More

By: Judy Mathias
June 22, 2018
Share

Joint Commission seeking comments on anticoagulation NPSG

Editor's Note The Joint Commission announced on June 20 that it is seeking comments on proposed changes to the National Patient Safety Goal (NPSG) 03.05.01 on reducing harm from anticoagulant therapy. Revised requirements, which will address the use of new direct oral anticoagulant medications, include: drug selection dosing and monitoring…

Read More

By: Judy Mathias
June 22, 2018
Share

Atul Gawande named CEO of new Amazon led healthcare company

Editor's Note Surgeon and Harvard Medical School professor Atul Gawande, MD, has been named CEO of the Boston-based Amazon, JP Morgan Chase, and Berkshire Hathaway healthcare venture, the June 20 Modern Healthcare reports. The companies, which are focused on lowering the cost of care primarily for their nearly 1.2 million…

Read More

By: Judy Mathias
June 20, 2018
Share

ALS by physicians linked to increased survival

Editor's Note In patients with traumatic out-of-hospital cardiac arrest (OHCA) after traffic collisions, advanced life support (ALS) performed by physicians was associated with increased chance of 1-month survival compared with ALS or basic life support (BLS) performed by emergency medical services (EMS) personnel, this Japanese study finds. Of 4,328 patients…

Read More

By: Judy Mathias
June 20, 2018
Share

Effectiveness of reprocessing reusable flexible bronchoscopes

Editor's Note In a study on the effectiveness of reprocessing flexible bronchoscopes presented June 14 by Ofstead and Associates at the Association for Professionals in Infection Control’s annual conference in Minneapolis, the majority of bronchoscopes were found to be contaminated and damaged even when cleaned and high-level disinfected according to…

Read More

By: Judy Mathias
June 20, 2018
Share

FDA letter updates risks of Type III endoleaks with aortic endovascular graft systems

Editor's Note In a June 19 letter to healthcare providers, the Food & Drug Administration (FDA) says it continues to evaluate information from several sources, including manufacturers, on the risks associated with Type III endoleaks with various endovascular graft systems used for treatment of abdominal aortic aneurysms (AAAs) and aorto-iliac…

Read More

By: Judy Mathias
June 20, 2018
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat